Early Erythropoietin Administration does not Increase the Risk of Retinopathy in Preterm Infants
Erythropoietin (EPO) administration prevents anemia of prematurity and may be associated with a significant increase in the risk of retinopathy of prematurity (ROP) in preterm infants. Nonetheless, early EPO treatment may prevent damage following retinal neovascularization. The aim of this meta-anal...
Main Authors: | Hsin-Hsu Chou, Mei-Yung Chung, Xiao-Guang Zhou, Hung-Chih Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-02-01
|
Series: | Pediatrics and Neonatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1875957216300638 |
Similar Items
-
Effect of early prophylactic low-dose recombinant human erythropoietin on retinopathy of prematurity in very preterm infants
by: Huiqing Sun, et al.
Published: (2020-10-01) -
Serum Erythropoietin, Insulin-Like Growth Factor 1 and Vascular Endothelial Growth Factor in Ethiopathogenesis of Retinopathy of Prematurity
by: Özlem Yenice, et al.
Published: (2012-12-01) -
The Role of Retinopathy Anemia in the Pathogenesis of Retinopathy of Prematurity and the Effect of Erythropoietin Treatment on the Frequency and Severity of the Disease
by: V. I. Lebedev, et al.
Published: (2020-11-01) -
EARLY ADMINISTRATION OF ERYTHROPOIETIN IN EXTREMELY VERY LOW BIRTH WEIGHT PRETERMS
by: Mihaela Demetrian, et al.
Published: (2019-09-01) -
Factors Associated with Retinopathy of Prematurity in Hospitalized Preterm Infants in Sanandaj, Iran
by: Majid Mansouri, et al.
Published: (2016-09-01)